Tirzepatide's effects on fertility: what the evidence says

Step 1, Understand the current safety position before making any decisions

The starting point is the medicine's licensed use. Tirzepatide's Summary of Product Characteristics (the formal document governing how it is prescribed in the UK) does not recommend use during pregnancy. Manufacturers conducted reproductive studies in animals that showed adverse developmental effects at doses relevant to human exposure, though animal data do not map directly onto human outcomes. What this means practically is that the prescribing community treats pregnancy exposure as a situation to avoid until human safety data exist, which they do not yet in meaningful volume. The NHS medicines information for tirzepatide reflects this clearly: stop treatment and speak to a doctor immediately if pregnancy occurs during treatment.

The position on trying to conceive is similar but requires more nuance. There is no MHRA-mandated washout period published specifically for tirzepatide in the way that some teratogenic medicines carry one, but the consensus from prescribers is to discontinue before attempting conception and to allow time for the medicine to clear. The effect Mounjaro may have on fertility more broadly is covered in detail elsewhere; the key point here is that no decision about timing should be made without clinical input.

If you are already on treatment and pregnancy is being planned, raise it at your next clinical review rather than stopping on your own.

Step 2, Address the contraception question now, not after your first dose

This is the aspect of tirzepatide's effects on fertility that catches people off guard. Tirzepatide slows gastric emptying, which can reduce the absorption of orally taken medicines, including the combined oral contraceptive pill. NHS England's guidance on weight-management injections is explicit: women on oral contraceptives should add a reliable non-oral method, such as condoms, for the first four weeks of starting tirzepatide and for four weeks after every upward dose step. Progesterone-only pills taken orally carry the same caveat.

Non-oral contraception, including patches, the hormonal coil, implants and injections, is not affected in the same way. If you are unsure which category your current contraception falls into, your GP or a sexual health clinic can advise before your treatment begins. The question of how Mounjaro affects fertility and contraception is one our prescribers are asked regularly, it is worth getting a straight answer before your pen arrives.

This step matters practically. An unintended pregnancy on tirzepatide is the precise situation the licensing guidance is designed to prevent. Getting contraception right at the outset removes that risk entirely.

Step 3, Weigh up what is genuinely unknown about tirzepatide and human fertility

A common question is whether tirzepatide might improve fertility in people with conditions such as polycystic ovary syndrome, where insulin resistance and excess weight are both factors. The logic is plausible: weight reduction and improved insulin sensitivity can restore ovulation in some people with PCOS, and tirzepatide produces meaningful reductions in both. Some early clinical data and case reports point in this direction, but there are no large randomised trials in humans specifically examining tirzepatide and fertility outcomes. It would be misleading to present this as an established benefit.

Our Mounjaro fertility page covers the PCOS angle in more depth. The position for anyone considering tirzepatide as a route to improving fertility-related outcomes is clear: speak to a reproductive specialist or endocrinologist alongside your prescriber. Weight management treatment and fertility treatment are separate clinical conversations, even when one informs the other. The effects of tirzepatide during pregnancy are a related but distinct topic if that is relevant to your situation.

The honest summary is that the direct human evidence base on tirzepatide and fertility is still thin. What is established is the safety boundary: not during pregnancy, not while breastfeeding, not while actively trying to conceive, and our guidance on whether you can drink alcohol on Mounjaro covers another lifestyle consideration that is worth reviewing before you start treatment. Everything else sits in the category of emerging or extrapolated evidence.

Step 4, Know who to involve and when to act

Fertility-adjacent questions about tirzepatide should not be resolved by a single conversation. The people worth involving are: your GP, who can review your overall health picture; a specialist if PCOS, endocrine conditions or previous fertility difficulties are relevant; and the prescriber managing your weight-loss treatment, who can advise on timing and any appropriate pause in treatment. At nume, every repeat order is clinically re-reviewed by a GPhC-registered Independent Prescriber, not passed through automated renewal, which means changes in your circumstances, including fertility planning, can be raised directly.

If you are at the stage of exploring tirzepatide for weight management and want to understand how it fits with your plans around conceiving, the right starting point is a structured clinical assessment. You can check your eligibility and start a free consultation with our prescribing team, who can give you a clear, personal answer rather than a general one. For broader background on what treatment through a regulated UK pharmacy actually involves, the weight-loss treatment overview is a useful place to start.

Practical note: if treatment is approved and dispatched, your pen arrives via DPD the next working day in plain, unmarked packaging, the tracking notification comes to your phone, and nothing on the outside identifies the contents.